Skip to main content
Caplight Logo









Dosium

Dosium

Private
LondonHealthcare & Life Scienceshttps://www.dosium.com/

Last Round

Grant

Mar 1, 2025

Company Overview

Dosium is a digital health company that provides a clinical decision support platform designed to improve accuracy in electronic prescribing and reduce medication errors.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Non-AI

Keywords

clinical decision supportCDSSmedication safetyelectronic health recordsEHRmedication dosinghealth techdigital healthFHIRelectronic prescribingEPMAclinical interoperabilityhealthcare APIpediatric safetymedication error prevention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dosium Comparables

Compare Dosium with similar companies based on industry and business-model similarity.

Dosium comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PEDeus Health AG
89%
SafeDose, Inc.
79%
Handtevy
78%

Dosium Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 1, 2025
Corporate FundingAug 1, 2024

Key People

Founding team and executive leadership

John Morrell

Co-founder & CTO

Founding Team

Nicholas Appelbaum

Co-Founder and CEO

Founding Team

Dosium Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2025

    Received funding from NHS Innovation Accelerator and National Institute for Health and Care Research.

  • Aug 1, 2024

    Raised funding with the Royal College of Pharmacy as lead investor.

Dosium Filings

Explore SEC and related filing metadata, where available.

Dosium filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dosium's valuation, stock price, and market status.

Is Dosium a public or private company?

Dosium is a private company.

What is the current stock price of Dosium?

Dosium is a private company with no public stock price. Caplight tracks Dosium's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Dosium worth (valuation)?

Valuation information for Dosium is not publicly available.

Can I buy Dosium stock?

Dosium shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dosium's last funding round?

Dosium's most recent funding round was Grant on March 1, 2025.

Who are the main investors in Dosium?

Key investors in Dosium include NHS Innovation Accelerator, Caelestinus, National Institute for Health and Care Research.

Will Dosium IPO soon?

No public IPO plans have been announced for Dosium.

How can I track Dosium secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dosium's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range7
Year Founded2019
Last FundingMar 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?